Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. FDA Move “Beyond Our Borders” Begins With China

This article was originally published in PharmAsia News

Executive Summary

Congressional concerns over inspection oversight in the midst of a heparin safety scare have not dampened FDA's efforts to highlight its new overseas initiative, "FDA Beyond Our Borders.

You may also be interested in...



U.S. FDA, PDA Kick Off First Conference On Quality Systems For China’s Manufacturers, Suppliers

SHANGHAI - The U.S. FDA, the Parenteral Drug Association and the respective local Chinese FDA jointly held the first education seminar on quality systems in Shanghai and Beijing in late April

U.S. FDA, PDA Kick Off First Conference On Quality Systems For China’s Manufacturers, Suppliers

SHANGHAI - The U.S. FDA, the Parenteral Drug Association and the respective local Chinese FDA jointly held the first education seminar on quality systems in Shanghai and Beijing in late April

U.S. FDA Triples Estimate On Deaths Following Allergic Reaction To Blood Thinner Heparin

BEIJING - U.S. FDA last week issued a sharply higher estimate on the number of deaths that have occurred in patients who suffered allergic reactions to the blood thinner heparin

Related Content

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel